Zero One AI Co., Ltd. (CEO Song Jun-ho), a leading medical artificial intelligence platform technology company, successfully completed the recently held online medical artificial intelligence competition at Seoul National University Hospital by providing ‘medical security data specialized artificial intelligence analysis environment (AI SaaS Solution)’. It was announced on the 12th.
The competition was held in eight areas: ▲ Pediatric intestinal pathology imaging data ▲ Nuclear medicine imaging data ▲ Sleep imaging data ▲ Voice spectrum data ▲ Acute kidney injury prediction ▲ Robotic surgery imaging data ▲ Atopy severity determination ▲ Pressure ulcer stage classification, It was conducted in a web-based artificial intelligence analysis environment where medical data leaks can be prevented at the source.
Zero One AI supplied ‘Cloud Native’ technology for this medical security data artificial intelligence competition project.
Through this technology, services such as external package installation access control, real-time medical data set mounting, real-time AI analysis environment container automatic management, and GPU dynamic automatic optimization were provided. The cost of expensive GPUs was reduced by more than 70% through the scoring automation function based on real-time artificial intelligence automatic inference technology.
In addition, the company announced that it provided an artificial intelligence analysis infrastructure platform with enhanced security based on the ability to store and track all coding history of data scientists, which served as an opportunity for the company to become a leading medical artificial intelligence platform company.
This medical artificial intelligence competition is an artificial intelligence linked to Seoul National University Hospital’s MAIC (Medical Artificial Intelligence Challenge) and Seoul National University Medical Big Data Research Center (MBRC)’s SAM (Solution with AI in Medicine) webpage. I used the platform. Zero1AI evaluated this competition as an important achievement that laid the foundation for further advancement of the medical artificial intelligence platform along with medical data open, sharing, and control policies in a future multi-hybrid cloud environment.
“The artificial intelligence platform is an essential support element for developing artificial intelligence models using medical data and utilizing artificial intelligence inference,” said Song Jun-ho, CEO of ZeroOne AI. “We have core capabilities in data governance technology, GPU control and optimization technology, and cloud native technology.” “We will lead the way,” he said.
Meanwhile, Zero One AI is the ‘K-Champ Challenge (KB Unicorn Club)’ incubation company of the Gyeonggi Center for Creative Economy and Innovation and is currently working with Seoul National University Hospital to develop ‘K-MIMIC (Korea Medical Information Mart for Intensive Care)’, a big data specialized for Korean intensive care patients. We are developing an AI model and a multi-hybrid artificial intelligence platform in the Ministry of Health and Welfare projects of ‘Development of ‘CDSS (Clinical Decision Support System)’, an AI-based clinical decision-making system, and ‘Development of AI CDSS to prevent high-risk drug prescription errors.’ .
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2022’ news